Day: November 19, 2024

# Simple Jiffy Corn Casserole Recipe: A Beloved Comfort Food

Corn casserole is a cherished dish that provides warmth and satisfaction to any dining experience. It’s a common choice at family events, potlucks, and festive dinners. One of the most straightforward and favored methods to create this scrumptious dish is by using Jiffy Corn Muffin Mix. This recipe is not only easy but also remarkably tasty, making it a favorite for both beginner cooks and experienced chefs. In this article, we will delve into the ingredients, steps for preparation, and some tips to enhance your Jiffy Corn Casserole experience.

## Ingredients

For a simple Jiffy Corn Casserole, gather the following items:

– **1 box of Jiffy Corn Muffin Mix** (8.5 oz)
– **1 can of whole kernel corn** (15 oz), drained
– **1 can of cream-style corn** (15 oz)
– **1 cup of sour cream**
– **1/2 cup of melted butter** (1 stick)
– **1 cup of shredded cheese** (optional, to boost flavor)
– **Salt and pepper** to taste

### Optional Add-Ins:
– **Chopped jalapeños** for some heat
– **Diced bell peppers** for extra color and taste
– **Cooked bacon bits** for a savory flair
– **Chopped green onions** for decoration

## Preparation Steps

### Step 1: Preheat the Oven
Start by preheating your oven to 350°F (175°C). This step assures that your casserole bakes uniformly.

### Step 2: Combine the Ingredients
In a large mixing bowl, mix together:
– The Jiffy Corn Muffin Mix
– The drained whole kernel corn
– The cream-style corn
– The sour cream
– The melted butter

Stir until all the components are thoroughly combined. If you’re including cheese or any optional ingredients, gently fold them in at this point.

### Step 3: Season
Add salt and pepper as needed. Keep in mind that the cheese (if included) may contribute some saltiness, so adjust accordingly.

### Step 4: Pour into Baking Dish
Grease a 9×13-inch baking dish with cooking spray or butter. Pour the corn mixture into the dish, spreading it out evenly.

### Step 5: Bake
Put the casserole in the preheated oven and bake for 45-55 minutes, or until the top turns golden brown and a toothpick inserted in the middle comes out clean.

### Step 6: Cool and Serve
After baking, take the casserole out of the oven and allow it to cool for a few minutes. This will help it set a little more. Serve warm, garnished with chopped green onions if you like.

## Tips for the Ideal Corn Casserole

1. **Try Different Cheeses**: While cheddar cheese is a traditional favorite, don’t hesitate to explore other varieties like pepper jack, mozzarella, or a mix for a distinctive flavor.

2. **Incorporate Herbs and Spices**: Fresh herbs such as parsley or thyme can enliven the dish. A dash of paprika or cayenne pepper can introduce an extra flavor dimension.

3. **Prepare in Advance**: This casserole can be made a day ahead. Just mix the ingredients, cover, and refrigerate. When you’re ready to serve, bake as instructed, adding a few more minutes to the cooking time.

4. **Serving Recommendations**: Jiffy Corn Casserole complements grilled meats, roasted vegetables, or can serve as a side for festive meals. It can also be relished on its own as a filling vegetarian option.

5. **Storage**: Leftovers can be kept in an airtight container in the fridge for up to 3 days. Reheat in the microwave or oven until hot throughout.

## Conclusion

The Simple Jiffy Corn Casserole is an adaptable dish that is sure to delight everyone. Its easy preparation and comforting taste make it a favorite for any event. Whether you’re serving it at a family gathering or enjoying it as a comforting weeknight meal, this corn casserole is bound to become a treasured recipe in your kitchen. So gather your ingredients, preheat that oven, and prepare to indulge in a slice of comfort!

**Vitality Expands Behavioral Change Services with Acquisition of Coaching Provider WellSpark**

In a strategic move to enhance its behavioral change services, Vitality, a global leader in health and wellness solutions, has announced the acquisition of WellSpark Health, a leading provider of health coaching and wellness programs. This acquisition marks a significant step in Vitality’s mission to empower individuals to lead healthier lives by expanding its portfolio of personalized, evidence-based wellness solutions.

### The Growing Importance of Behavioral Change in Health and Wellness

In recent years, there has been a growing recognition of the importance of behavioral change in achieving long-term health outcomes. Chronic conditions such as diabetes, heart disease, and obesity are often driven by lifestyle factors, including poor diet, lack of physical activity, and stress. Addressing these factors requires more than just medical interventions; it requires a fundamental shift in behavior.

Behavioral change programs, which focus on helping individuals adopt healthier habits, have become a cornerstone of modern wellness strategies. These programs typically involve personalized coaching, goal-setting, and ongoing support to help individuals make sustainable changes in their daily lives. By acquiring WellSpark, Vitality is positioning itself at the forefront of this movement.

### Who is WellSpark?

WellSpark Health is a well-established provider of wellness and health coaching services, with a strong focus on helping individuals manage chronic conditions and improve their overall well-being. The company offers a range of services, including personalized health coaching, disease management programs, and wellness workshops. WellSpark’s approach is rooted in behavioral science, with a focus on empowering individuals to take control of their health through education, motivation, and support.

WellSpark has built a reputation for delivering high-quality, evidence-based programs that are tailored to the unique needs of each individual. Their team of certified health coaches works closely with participants to develop personalized wellness plans, set achievable goals, and provide ongoing support and encouragement. This personalized approach has been shown to be highly effective in helping individuals make lasting changes to their health behaviors.

### Synergies Between Vitality and WellSpark

Vitality has long been a pioneer in the health and wellness industry, offering a comprehensive suite of digital tools, incentives, and resources designed to promote healthier lifestyles. The company’s innovative approach combines technology, behavioral science, and rewards to encourage individuals to make positive health choices. By integrating WellSpark’s coaching expertise into its existing platform, Vitality aims to provide a more holistic and personalized experience for its users.

The acquisition of WellSpark will allow Vitality to expand its behavioral change services in several key areas:

1. **Personalized Coaching**: WellSpark’s health coaching programs will complement Vitality’s existing digital tools, providing users with one-on-one support from certified health coaches. This personalized approach will help individuals set realistic goals, overcome barriers, and stay motivated on their wellness journey.

2. **Chronic Condition Management**: WellSpark has a strong track record in helping individuals manage chronic conditions such as diabetes, hypertension, and obesity. By integrating these services into its platform, Vitality will be able to offer more targeted interventions for individuals with specific health needs.

3. **Behavioral Science Expertise**: Both companies share a commitment to evidence-based practices rooted in behavioral science. The acquisition will allow Vitality to leverage WellSpark’s expertise in behavior change to enhance the effectiveness of its programs and improve health outcomes for its users.

4. **Expanded Reach**: WellSpark’s established network of clients and partners will enable Vitality to reach a broader audience, including employers, health plans, and individuals seeking wellness solutions. This expanded reach will help Vitality scale its impact and bring its innovative wellness programs to more people.

### The Future of Wellness: A Holistic Approach

The acquisition of WellSpark reflects a broader trend in the wellness industry toward more holistic, personalized approaches to health. Rather than focusing solely on physical health, modern wellness programs are increasingly addressing the mental, emotional, and social factors that influence well-being. This holistic approach recognizes that true health is about more than just the absence of disease; it is about thriving in all aspects of life.

With the integration of WellSpark’s coaching services, Vitality is well-positioned to lead this shift toward holistic wellness. By combining cutting-edge technology with personalized coaching and behavioral science, Vitality will be able to offer a comprehensive solution that addresses the full spectrum of health and well-being.

### Conclusion

The acquisition of WellSpark by Vitality represents a significant milestone in the evolution of wellness programs. By expanding its behavioral change services, Vitality is taking a proactive approach to helping individuals lead healthier, more fulfilling lives. With a focus on personalized coaching, chronic condition management, and evidence-based practices, the combined strengths of Vitality and WellSpark will provide users with the tools and support they need to make lasting changes to their health.

As the wellness industry continues to evolve, the integration of technology, coaching, and behavioral science will play an increasingly important role in shaping the future of health. With this acquisition, Vital

**Citizen Health Raises $14.5 Million in Seed Funding to Advance Drug Development for Rare Diseases**

*October 2023* — Citizen Health, a pioneering biotech company focused on accelerating drug development for rare diseases, has successfully raised $14.5 million in seed funding. This significant financial boost will enable the company to further its mission of addressing the unmet medical needs of patients suffering from rare and often overlooked conditions. The funding round was led by prominent venture capital firms, with participation from several angel investors and patient advocacy groups.

### Addressing a Critical Gap in Healthcare

Rare diseases, also known as orphan diseases, affect a small percentage of the population, but collectively, they impact millions of people worldwide. According to the National Institutes of Health (NIH), there are over 7,000 rare diseases, affecting approximately 30 million Americans and 300 million people globally. Despite the large number of patients affected, only a small fraction of these diseases have approved treatments. This is largely due to the high costs and extended timelines associated with traditional drug development, which often dissuades pharmaceutical companies from investing in treatments for smaller patient populations.

Citizen Health aims to change this paradigm by leveraging cutting-edge technologies and innovative research methodologies to streamline the drug discovery and development process. The company’s approach focuses on reducing the time and cost required to bring new therapies to market, ensuring that patients with rare diseases have access to life-saving treatments sooner.

### The Role of Technology in Accelerating Drug Development

Citizen Health is utilizing a combination of artificial intelligence (AI), machine learning (ML), and advanced data analytics to identify potential drug candidates more efficiently. By analyzing vast datasets, including genetic information, clinical trial data, and patient outcomes, the company’s platform can pinpoint promising therapeutic targets for rare diseases that have been historically difficult to treat.

Additionally, Citizen Health is committed to fostering collaboration among researchers, clinicians, and patient advocacy groups. The company’s platform allows stakeholders to share data and insights, accelerating the pace of discovery and ensuring that research efforts are aligned with the most pressing needs of the rare disease community.

### A Patient-Centric Approach

One of the key differentiators of Citizen Health is its patient-centric approach to drug development. The company works closely with patient advocacy groups and rare disease communities to ensure that the voices of patients and their families are heard throughout the drug development process. This collaborative approach helps to prioritize the development of therapies that address the most urgent needs of patients, while also ensuring that clinical trials are designed with patient well-being in mind.

“We believe that patients should be at the center of everything we do,” said Dr. Emily Carter, CEO of Citizen Health. “By partnering with rare disease communities, we can better understand the challenges they face and develop treatments that truly make a difference in their lives.”

### The Importance of Seed Funding

The $14.5 million in seed funding will be instrumental in helping Citizen Health advance its research and development efforts. The company plans to use the funds to expand its team of scientists, engineers, and data analysts, as well as to invest in the development of its AI-driven drug discovery platform. Additionally, the funding will support preclinical studies and early-stage clinical trials for several promising drug candidates in the company’s pipeline.

“We are incredibly grateful for the support of our investors, who share our vision of transforming the way rare diseases are treated,” said Dr. Carter. “This funding will allow us to accelerate our efforts and bring new therapies to patients who desperately need them.”

### A Growing Focus on Rare Diseases

Citizen Health’s successful seed funding round comes at a time when there is growing interest in rare diseases within the biotech and pharmaceutical industries. In recent years, regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have introduced incentives to encourage the development of orphan drugs, including tax credits, grants, and market exclusivity for approved therapies. These incentives, combined with advances in technology and a greater understanding of the genetic basis of many rare diseases, have led to an increase in investment in this area.

However, despite these positive developments, there is still much work to be done. Many rare diseases remain poorly understood, and the majority of patients continue to face limited treatment options. Citizen Health’s innovative approach has the potential to make a significant impact by accelerating the discovery of new therapies and improving the lives of patients with rare diseases.

### Looking Ahead

With its newly secured seed funding, Citizen Health is well-positioned to make meaningful strides in the fight against rare diseases. The company’s focus on leveraging technology, fostering collaboration, and prioritizing patient needs sets it apart in the biotech landscape. As Citizen Health continues to grow and advance its drug development pipeline, it has the potential to bring hope to millions of patients and families affected by rare diseases around the world.

In the coming months, the biotech community will be watching closely as Citizen Health embarks on the next phase of its journey. If successful, the company could play a

**DigitalOwl and ExamOne Announce Partnership for Streamlined Medical Record Retrieval and Analysis**

In today’s fast-paced digital landscape, the demand for efficient and accurate medical record retrieval and analysis is more critical than ever. Insurance companies, healthcare providers, and other stakeholders rely on timely access to medical data to make informed decisions. Recognizing this need, **DigitalOwl** and **ExamOne** have announced a strategic partnership aimed at revolutionizing the way medical records are retrieved, analyzed, and utilized across the insurance and healthcare industries.

### Who Are DigitalOwl and ExamOne?

**DigitalOwl** is a leading provider of advanced artificial intelligence (AI) solutions designed to streamline the analysis of medical records. The company’s proprietary technology uses machine learning algorithms to extract relevant medical information from unstructured data, significantly reducing the time and effort required to review complex medical histories. DigitalOwl’s platform delivers concise, structured, and actionable summaries, which are especially valuable for underwriting, claims processing, and risk assessment in the insurance industry.

**ExamOne**, a Quest Diagnostics company, is a well-established provider of risk assessment services for the life insurance industry. With a comprehensive suite of services that includes medical record retrieval, laboratory testing, and paramedical exams, ExamOne has long been a trusted partner for insurance carriers looking to streamline their underwriting processes. The company’s extensive network and experience in medical data collection have made it a leader in the field.

### The Partnership: A Game-Changer for Medical Record Retrieval and Analysis

The collaboration between DigitalOwl and ExamOne is poised to transform the way medical records are handled in the insurance and healthcare sectors. By combining ExamOne’s expertise in medical record retrieval with DigitalOwl’s cutting-edge AI-driven analysis, the partnership aims to provide a more efficient, accurate, and scalable solution for managing medical data.

#### Key Benefits of the Partnership:

1. **Faster Turnaround Times**:
One of the most significant advantages of this partnership is the reduction in time required to retrieve and analyze medical records. Traditionally, reviewing medical records is a labor-intensive process that can take days or even weeks. By leveraging DigitalOwl’s AI technology, insurers and healthcare providers can now receive structured summaries of medical records in a fraction of the time, allowing for quicker decision-making.

2. **Improved Accuracy and Consistency**:
Human error is always a risk when manually reviewing large volumes of medical data. DigitalOwl’s AI algorithms are designed to minimize these errors by consistently extracting and organizing relevant information. This ensures that critical details are not overlooked, leading to more accurate risk assessments and underwriting decisions.

3. **Enhanced Efficiency for Underwriters and Claims Processors**:
The partnership will enable underwriters and claims processors to focus on higher-value tasks by automating the time-consuming process of medical record review. With AI-generated summaries, professionals can quickly access the most pertinent information needed to make informed decisions, improving overall productivity.

4. **Scalability**:
As the volume of medical records continues to grow, the ability to scale efficiently becomes increasingly important. The combined solution offered by DigitalOwl and ExamOne is designed to handle large volumes of data, making it an ideal choice for insurance carriers and healthcare providers of all sizes.

5. **Data Security and Compliance**:
Both companies place a strong emphasis on data security and compliance with industry regulations, such as the Health Insurance Portability and Accountability Act (HIPAA). The partnership ensures that sensitive medical information is handled with the utmost care, providing peace of mind to both insurers and policyholders.

### How the Partnership Works

The process begins with ExamOne retrieving medical records from healthcare providers, a task the company has been performing for decades. Once the records are obtained, they are fed into DigitalOwl’s AI platform, which analyzes the unstructured data and generates a structured, easy-to-read summary. This summary highlights key medical events, diagnoses, treatments, and other relevant information, allowing underwriters and claims processors to quickly assess the applicant’s health status.

The AI-generated summaries are designed to be highly customizable, allowing insurers to tailor the output to their specific needs. For example, an insurer may choose to focus on certain medical conditions or timeframes, depending on the nature of the policy being underwritten.

### Industry Implications

The partnership between DigitalOwl and ExamOne is expected to have far-reaching implications for the insurance and healthcare industries. As the demand for faster, more accurate medical record analysis grows, the combined solution offered by these two companies will likely become a standard in the industry.

For life insurers, in particular, the ability to quickly and accurately assess an applicant’s medical history is crucial for determining risk and setting premiums. By streamlining this process, the partnership will help insurers improve their underwriting efficiency, reduce costs, and enhance the customer experience.

In the healthcare sector, the partnership could also have a significant impact on patient care. By providing healthcare providers with faster

# Creamy Buttermilk Mashed Potatoes Recipe

Mashed potatoes represent a timeless comfort food found on tables globally, particularly during festive occasions and family reunions. Although classic mashed potatoes are certainly tasty, incorporating buttermilk elevates this dish to an entirely new realm of creaminess and taste. This article will provide you with a straightforward yet enjoyable recipe for creamy buttermilk mashed potatoes, ideal for any event.

## Why Buttermilk?

Buttermilk is a fermented dairy product that contributes a zesty flavor and a smooth texture to recipes. It contains less fat compared to heavy cream, making it a healthier option while still delivering richness. The acidity found in buttermilk assists in breaking down the starches in potatoes, leading to a creamier, silkier mash.

## Ingredients

To prepare creamy buttermilk mashed potatoes, you will require the following ingredients:

– **2 pounds of potatoes** (Yukon Gold or Russet potatoes work wonderfully)
– **1/2 cup buttermilk** (at room temperature)
– **1/4 cup unsalted butter** (plus additional for serving, if desired)
– **Salt** (to taste)
– **Freshly ground black pepper** (to taste)
– **Optional ingredients**: garlic (roasted or sautéed), chives, or sour cream for added flavor

## Instructions

### Step 1: Prepare the Potatoes

1. **Peel and Cut**: Start by peeling the potatoes and cutting them into even chunks (approximately 1-2 inches). This promotes uniform cooking.

2. **Rinse**: Rinse the potato chunks under cold water to eliminate excess starch, which can lead to a gummy texture.

### Step 2: Boil the Potatoes

1. **Cook**: Place the potato chunks in a sizable pot and cover them with cold water. Sprinkle in a generous pinch of salt. Bring the water to a boil over medium-high heat.

2. **Simmer**: After reaching a boil, decrease the heat to medium and allow the potatoes to simmer for about 15-20 minutes or until fork-tender.

### Step 3: Drain and Dry

1. **Drain**: Carefully drain the potatoes in a colander and allow them to sit for a few minutes to let any excess moisture evaporate. This step is vital for achieving fluffy mashed potatoes.

### Step 4: Mash the Potatoes

1. **Mash**: Return the drained potatoes to the pot. Utilize a potato masher, ricer, or food mill to mash the potatoes until they attain your preferred consistency. For an exceptionally smooth texture, using a ricer or food mill is suggested.

### Step 5: Add Buttermilk and Butter

1. **Mix**: While the potatoes remain warm, incorporate the buttermilk and butter. Stir gently with a wooden spoon or spatula until the butter has melted and the mixture is well blended.

2. **Season**: Sample the mashed potatoes and season with salt and freshly ground black pepper according to your tastes. If you’re adding any optional ingredients like roasted garlic or chives, mix them in at this point.

### Step 6: Serve

1. **Plate**: Transfer the creamy buttermilk mashed potatoes to a serving bowl. If you wish, top with an additional pat of butter and a sprinkle of chives or parsley for garnish.

2. **Enjoy**: Serve warm with your favorite main dishes, such as roasted meats, gravy, or vegetable sides.

## Tips for Perfect Mashed Potatoes

– **Choose the Right Potatoes**: Yukon Gold potatoes provide a buttery flavor and creamy consistency, while Russets are fluffier. You can also combine both for a unique flavor.
– **Don’t Overmix**: Overworking the potatoes may result in a gluey consistency. Mix just until combined.
– **Adjust Consistency**: If you prefer creamier mashed potatoes, feel free to add more buttermilk or butter until you achieve your desired texture.

## Conclusion

Creamy buttermilk mashed potatoes present a delightful variation on a traditional favorite, offering an ideal mix of creaminess and tang. This recipe is not only simple but also adaptable, allowing you to personalize it to your preferences. Whether enjoyed at a festive gathering or a laid-back dinner at home, these mashed potatoes are sure to please and satisfy. Indulge in the rich flavors and creamy consistency that will leave everyone wanting more!

# Lunit and AstraZeneca Collaborate on AI-Powered Digital Pathology: Key Updates and Industry Briefs

The healthcare industry is undergoing a transformative shift, driven by advancements in artificial intelligence (AI) and digital technologies. One of the most promising areas of this transformation is the field of digital pathology, where AI-powered tools are being developed to assist pathologists in diagnosing diseases more accurately and efficiently. A recent collaboration between **Lunit**, a leading AI-driven medical software company, and **AstraZeneca**, a global biopharmaceutical giant, marks a significant milestone in this domain. This partnership aims to leverage AI technology to enhance the accuracy and efficiency of cancer diagnosis and treatment, particularly in the field of oncology.

### Overview of the Collaboration

In early 2023, Lunit and AstraZeneca announced a strategic collaboration to integrate AI-powered digital pathology solutions into AstraZeneca’s oncology pipeline. The partnership is centered around Lunit’s cutting-edge AI technology, which is designed to analyze tissue samples and provide insights that can assist pathologists in identifying cancerous cells and predicting patient responses to various treatments.

The collaboration will focus on two key areas:

1. **Improving Diagnostic Accuracy**: Lunit’s AI algorithms are designed to assist pathologists in identifying cancerous tissues with greater precision. By analyzing large datasets of pathology images, the AI can detect patterns that may be missed by the human eye, thus improving the accuracy of diagnoses.

2. **Enhancing Treatment Personalization**: AstraZeneca, known for its innovative cancer therapies, aims to use Lunit’s AI technology to better understand how individual patients respond to specific treatments. By integrating AI-powered pathology insights into clinical trials and treatment protocols, the collaboration seeks to personalize cancer treatment, ensuring that patients receive the most effective therapies based on their unique pathology profiles.

### Key Updates on the Collaboration

#### 1. **AI-Powered Biomarker Analysis**
One of the most exciting aspects of the collaboration is the use of AI to analyze biomarkers in tissue samples. Biomarkers are biological indicators that can provide valuable information about a patient’s disease state and potential response to treatment. Lunit’s AI tools are designed to identify these biomarkers with high accuracy, allowing for more precise treatment decisions.

For example, in the case of non-small cell lung cancer (NSCLC), a common and deadly form of cancer, Lunit’s AI can analyze tissue samples to identify specific biomarkers that indicate whether a patient is likely to respond to immunotherapy. This information can help oncologists tailor treatment plans to the individual needs of each patient, improving outcomes and reducing the risk of ineffective treatments.

#### 2. **Integration into Clinical Trials**
AstraZeneca has a robust pipeline of cancer therapies, many of which are currently in clinical trials. As part of the collaboration, Lunit’s AI technology will be integrated into these trials to provide real-time pathology insights. This will allow researchers to better understand how patients are responding to experimental treatments and adjust trial protocols accordingly.

By incorporating AI-powered pathology into clinical trials, AstraZeneca hopes to accelerate the development of new cancer therapies and bring them to market more quickly. Additionally, the use of AI in trials could help identify patient subgroups that are more likely to benefit from specific treatments, further advancing the goal of personalized medicine.

#### 3. **Regulatory Approvals and Market Expansion**
Lunit’s AI solutions have already received regulatory approvals in several countries, including the United States, South Korea, and the European Union. As part of the collaboration, AstraZeneca will work with Lunit to expand the availability of these AI tools to new markets, particularly in regions where access to advanced pathology services is limited.

The collaboration also aims to secure additional regulatory approvals for new AI-powered diagnostic tools, paving the way for broader adoption of digital pathology in clinical practice. By making these tools more widely available, Lunit and AstraZeneca hope to improve cancer care on a global scale.

### Industry Implications

The collaboration between Lunit and AstraZeneca is part of a broader trend in the healthcare industry, where AI is increasingly being integrated into diagnostic and treatment workflows. Digital pathology, in particular, is emerging as a key area of focus, as AI-powered tools have the potential to address several challenges faced by pathologists and oncologists.

#### 1. **Addressing the Pathologist Shortage**
One of the major challenges in the field of pathology is the global shortage of trained pathologists. In many regions, there are not enough pathologists to meet the growing demand for diagnostic services, particularly in oncology. AI-powered digital pathology tools, like those developed by Lunit, can help alleviate this shortage by automating certain aspects of the diagnostic process. This allows pathologists to focus on more complex cases and reduces the time required to deliver accurate diagnoses.

#### 2. **Improving Diagnostic Consistency**
Another challenge in pathology is the variability in diagnostic accuracy between different pathologists. Studies have shown that even experienced pathologists can sometimes disagree on diagnoses, particularly in cases where